TP53 and cancer: In all processed samples non-neoplastic cell fractions were TP53 wild-type, whereas the post-sorting cancer cell eluate presented with a higher portion of the mutated allele compared to the original ascites (Figure 3B; Supplementary Figure 2B; Supplementary Table 2), demonstrating a successful enrichment of neoplastic cells.